Skip to main content

ImageneBio, Inc.

IMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001835579

In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding ImageneBio, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of IMA: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders54157+4
Shares32.4M3.00K30.1M−2.29M (−7.1%)
Value$63.8M$5.91K$42.7M−$21.1M (−33.0%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held ImageneBio, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to IMA in Q1 2024
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC776,600$1.10M0.00%
Acuitas Investments, LLC397,746$564.8K0.28%
Marshall Wace, LLP88,691$125.9K0.00%
Two Sigma Advisers, LP79,900$113.5K0.00%
Marquette Asset Management, LLC72,890$103.5K0.02%
XTX Topco Ltd35,272$50.1K0.01%
ADAR1 Capital Management, LLC35,000$49.7K0.01%
Prudential Financial Inc16,920$24.0K0.00%
Atom Investors LP10,155$14.4K0.00%
Farther Finance Advisors, LLC35$490.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC3$40.00%
CWM, LLC3$00.00%

Sold out (8)

Institutions that held ImageneBio, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of IMA in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Artal Group S.A.999,513$1.97M
Laurion Capital Management LP372,613$734.0K
Vestal Point Capital, LP322,671$635.7K
Vida Ventures Advisors, LLC225,192$443.6K
Anson Funds Management LP209,315$412.4K
Virtu Financial LLC26,882$53.0K
Jane Street Group, LLC22,072$43.5K
Susquehanna International Group, LLP20,170$39.7K

Not filed for Q1 2024 yet (1)

Institutions that held ImageneBio, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMA in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Baystate Wealth Management LLC2,999$5.91K